GASTRO 2024_ Event Postponement

This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.

Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.

For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.

HYBRID EVENT: You can participate in person at Baltimore, MD, USA or Virtually from your home or work.

2nd Edition of International Conference on Gastroenterology

October 21-23, 2024, Baltimore, Maryland, USA

October 21 -23, 2024 | Baltimore, MD, USA
Gastro 2023

Case study: Pseudomyxoma peritonei secondary to rectal mass adenocarcinoma: A rare clinical presentation

Speaker at Gastroenterology Conferences - Milaris M Sanchez Cordero
Milaris M Sanchez Cordero
Mayaguez Medical Center, Puerto Rico
Title : Case study: Pseudomyxoma peritonei secondary to rectal mass adenocarcinoma: A rare clinical presentation

Abstract:

Pseudomyxoma peritonei (PMP) is a rare malignant disease, involving the peritoneum, characterized by the production of large quantities of mucinous ascites. PMP has a low incidence of 2-4 per million people, it’s challenging to diagnose, and has a limited prognosis. Normally, it’s extremely rare but the most common presentation is PMP induced by low-grade appendiceal mucinous neoplasm. This reports a case of a 76-year-old female who presented to the Emergency Department due to abdominal pain, rectal mass with bleeding of several months of evolution. The patient has poor medical follow-up and has never had a colonoscopy before. A colonoscopy was performed on admission alongside a biopsy of the rectal mass that resulted with adenomatous colon mucosa with positive immunostain (CK-20). Pathology from ultrasound-guided biopsy results came back positive with PMP primarily from adenocarcinoma from the rectum. CEA resulted elevated. The patient presented with pulmonary embolism (PE) occluding the right-upper-lobe (RUL) with bilateral lower extremities deep vein thrombosis (DVT). Due to a hypercoagulable state, an inferior vena cava (IVC) filter was placed. Diagnostic laparoscopy was performed and resulted with carcinomatosis in the peritoneal cavity. An attempt to do a colostomy for the palliative process was not possible due to extension of tumor to bowel. Cytoreductive Surgery (CRS) associated with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is the optimal treatment for PMP. However, in patients with an extensive or recurrent disease, few therapeutic opportunities are available. In this case, tumor marker elevations correlate with worse prognosis and increased recurrence rates.
Keywords: Pseudomyxoma peritonei, rectal cancer, adenocarcinoma

Audience Take away:
• Management of a rare cause of cancer as pseudomyxoma peritonei
• Known about its rare presentation and the importance of early diagnosis
• Is this research that other faculty could use to expand their research or teaching? yes

Biography:

Dr. Sanchez studied Chemistry at the University of Puerto Rico, Rio Piedras Campus and graduated in 2015. She then started in Medical School in 2016 and finished it in May 2020. As the pandemia arrived, clinical rotations were delayed, and she decided to complete a master’s degree in Autism and Neurodevelopmental Disorders. Then she started in an internship for one year. In 2022 she got accepted in Internal Medicine Residency and is currently a first-year resident. She loved research since was an undergraduate student and participate in several research focused on Prostate Cancer. She is interested in Gastroenterology branch and her plans are to continue in this fellowship.

Quick Links

Watsapp